{"uuid": "a7cf0a87-2a9c-440c-b644-39f1804b775c", "tweet_id": "1338166058323222528", "replies": [], "reply_to": "1338162756709658624", "avatar": "https://pbs.twimg.com/profile_images/1402298659409039362/4Asq_mfl_normal.png", "user_handle": "jwoodgett", "user_name": "Jim Woodgett", "content": "Replying to @tschwarzromond @EricTopol and 3 others\nWhile sovereign independence of assessments is critical to drug safety, the risk/benefit ratio here under emergency use given release of data & ,  and  approvals surely expedites matters? Unless procurement is in doubt.", "date": "12:57 AM \u00b7 Dec 14, 2020\u00b7Tweetbot for i\u039fS", "engagement": "1 Like", "avatar_extension": "png"}